Aducanumab: First Approval

Dhillon, S

Dhillon, S (corresponding author), Springer Nat, Private Bag 65901, Auckland 0754, New Zealand.

DRUGS, 2021; 81 (12): 1437

Abstract

Aducanumab (aducanumab-avwa; Aduhelm (TM)) is a human, immunoglobulin gamma 1 (IgG1) monoclonal antibody directed against aggregated soluble and insol......

Full Text Link